Biomarker Found That Predicts Response To Chemotherapy For Osteosarcoma
7/05/2012
Discovery could refine treatment strategy for children with bone cancer Scientists have found that a protein expressed by some cancers is a good predictor of how the cancer will respond to standard chemotherapy for osteosarcoma, the most common bone cancer in children...
'Magic-Bullet' Cancer Therapy To Be Investigated
7/05/2012
Scientists at the University of Sheffield will investigate a new 'magic-bullet' cancer therapy that exploits tumour cells' greed for fat following an award from Yorkshire Cancer Research. Higher rates of the most deadly cancers, such as colorectal and breast cancer, have been linked to obesity or high fat diets because cancer cells use fat to grow larger and more dangerous...
Activity Of Rare Genetic Variant In Glioma Validated
7/05/2012
Researchers at Moffitt Cancer Center working with colleagues at three other institutions have validated a link between a rare genetic variant and the risk of glioma, the most common and lethal type of brain tumor. The validation study also uncovered an association between the same rare genetic variant and improved rates of survival for patients with glioma...
Risk Of Bladder Cancer May Increase With Some Diabetes Drugs
7/05/2012
An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal). People with type 2 diabetes are at risk of several types of cancer, including a 40% increased risk of bladder cancer, compared to people without diabetes...
Anticoagulant Drugs For Atrial Fibrillation - Safety Indicators Confirmed
7/05/2012
A new study by medical scientists coordinated from the University of Manchester has for the first time used patients' results to establish that "safety indicators" for people taking anticoagulant drugs to regulate a common heart condition are correct. More than 760,000 patients in the UK have atrial fibrillation (AF), a defect that causes an irregular heart rate...
A Surprising Culprit Behind Chemotherapy Resistance In Rare Cancer
7/04/2012
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy. Multiple myeloma is a rare cancer of plasma cells in the bone marrow. Though the finding has no immediate benefit for patients, the scientists say it could help guide research into better treatments...
New Way To Grow, Isolate Cancer Cells May Add Weapon Against Disease
7/04/2012
The news a cancer patient most fears is that the disease has spread and become much more difficult to treat. A new method to isolate and grow the most dangerous cancer cells could enable new research into how cancer spreads and, ultimately, how to fight it...
The Surprising Answer To Why Cancer Rate Increases With Age
7/04/2012
Cancers are age-related, much more frequent in the old than in the young. A University of Colorado Cancer Center review published in the journal Oncogene argues against the conventional wisdom that the accumulation of cancer-causing mutations leads to more cancer in older people, instead positing that it is the changing features of tissue in old age that promote higher cancer rates in the elderly...
Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage...
In Vitro Study Identifies Potential Combination Therapy For Breast Cancer
7/04/2012
A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise the possibility of using this type of combination therapy for different forms of breast cancer, including those that develop resistance to chemotherapy and other treatments...